Hysterectomy (uterus removal) Doctors Abroad — Page 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Li Huaifang specializes in gynecologic tumors, pelvic floor disorders, and minimally invasive gynecologic surgery. She has performed over 10,000 minimally invasive procedures and more than 5,000 pelvic floor repairs. Her work includes laparoscopic and hysteroscopic cancer operations. She also performs reconstructive surgery for prolapse and incontinence. She has demonstrated surgical techniques at national conferences.

Academic roles: National member, Pelvic Floor Dysfunction Group (CMA OBGYN). Deputy head, Shanghai MA OBGYN Pelvic Floor Group. Expert, Shanghai Gynecologic Quality Control Panel. She joined the 12th Five-Year Plan. She now leads a 14th Five-Year Plan sub-project on degradable pelvic floor meshes. Publications: 240+ papers, including 50+ SCI. Textbook co-author and supervisor at Tongji University with 50+ mentees. Honors include the Shanghai Medical S&T Award, the Chinese MCH S&T Award, and prizes for pelvic floor reconstruction in 2006, 2012, and 2015.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

The first gynecologist accredited by SERGS to operate using two robotic platforms – Dr. Paul Stanciu specializes in minimally invasive hysterectomies at Ponderas Academic Hospital.

• Subspecialist in Gynaecological Oncology and Robotic Surgery
• Trained at Royal Marsden Hospital and other renowned centers
• Performs complex, fertility-sparing surgeries for young cancer patients
• Author of numerous scientific articles on innovative techniques

Specializing in gynecologic oncology at Samsung Medical Center, Kim Tae Joong focuses on precision in hysterectomy procedures.

• Expert in oncogynecology for women's health
• Practices at Samsung Medical Center

Dr. Lee specializes in oncogynecology, focusing on comprehensive care for patients requiring hysterectomy at Samsung Medical Center.

• Expert in minimally invasive surgical techniques
• Dedicated to preserving patient quality of life post-surgery
• Works at one of South Korea's leading medical institutions

Professor Gilad Ben Baruch specializes in oncogynecology at Assuta Medical Center, focusing on complex gynecological surgeries.

• Expert in oncogynecology with years of specialized experience
• Performs advanced surgical techniques for gynecological conditions
• Works at Assuta Medical Center, a leading healthcare facility

Specialist in endoscopic and laparoscopic hysterectomies – Dr. Cohen focuses on minimally invasive techniques at Assuta Medical Center.

• Gynecologist with expertise in advanced surgical methods
• Performs procedures using laparoscopic technology
• Works at Israel's leading private hospital

Specialist in Obstetrics, Gynecology and Oncogynecology – Dr. Amnon brings focused expertise to hysterectomy procedures at Rambam Medical Center.

• Specializes in both obstetrics and oncogynecology
• Works at Rambam Medical Center, a leading healthcare institution
• Combines general gynecology with advanced oncological training

Dr. Levinstein specializes in obstetrics and gynecology at Rambam Medical Center.

• Expert in hysterectomy procedures
• Focuses on patient-centered care
• Works at a leading medical center

Professor Ami Fishman specializes in endoscopic and laparoscopic surgeries for gynecologic oncology at Herzliya Medical Center.

• Leading oncogynecologist and surgeon at Herzliya Medical Center
• Head of the Department of Obstetrics and Gynecology at Meir Medical Center
• Specializes in diseases of the uterus, cervix, and ovaries

Prof. Husslein leads the Obstetrics and Gynecology Department at Vienna General Hospital – one of Austria's top medical centers.

• Specializes in advanced gynecologic surgeries
• Expertise in minimally invasive techniques
• Oversees complex cases at a major teaching hospital

Dr. Yuliia Kochet is an Obstetrician-Gynecologist, Reproductologist with 17 years of experience and First Category specialization. She is a member of Ukrainian Association of Reproductive Medicine (UARM) and European Society of Reproduction and Embryology and has expertise in Assisted Reproductive Technologies, Ultrasound Diagnostics, Hysterosalpingography, Hysteroscopy, Laparoscopy, Radio Wave Surgery, and the treatment of uterus problems and STDs. She has experience with international seminars and conferences.

Dr. Iryna Babenko is a fertility specialist with 16 years of experience and a PhD and MD degree from the National Pyrohov Memorial Medical University Faculty of Medicine. She specializes in assisted reproductive technologies, treatment of infertility and miscarriage, operative gynecology, treatment for sexually transmitted diseases, endoscopic surgery in gynecology, and ultrasound diagnostics, and is a member of the Ukrainian Association of Reproductive Medicine and the European Society of Human Reproduction and Embryology.

Specialist in obstetrics & gynecology with over 24 years of experience – Dr. Douliotis focuses on individualized fertility treatments at Babydust Clinic.

• Subspecialist in fertility & assisted conception
• Member of the Royal College of Obstetricians & Gynaecologists
• Offers affordable fertility treatments to international patients

Assistant Professor at Istanbul Altınbaş University with over 20 publications – Dr. Sismanoglu combines academic research with clinical expertise in reproductive health.

• Specializes in IVF treatment, obstetrics, and infertility surgery
• Member of European Society of Human Reproduction and Embryology
• Frequently featured expert in Turkish media on reproductive health
• Multilingual team supporting international patients

Dr. Sitanan Panunumpa is the medical director at Siam Fertility in Bangkok. She performs over 300 IVF and ICSI cycles every year. She also completes over 200 gynecologic laparoscopic surgeries annually. Dr. Panunumpa earned a master’s in biotechnology of human assisted reproduction in Spain.

• Board-certified in reproductive medicine by Ramathibodi Hospital.
• Member of the American Society for Reproductive Medicine (ASRM).
• Member of the European Society of Human Reproduction and Embryology (ESHRE).
• Treats conditions like endometriosis, polycystic ovaries, and uterine fibroids.

Specialist in laparoscopic hysterectomy – Dr. Lee focuses on minimally invasive techniques at Gachon University Gil Medical Center.

• Oncogynecologist with expertise in laparoscopic operations
• Performs uterus removal with smaller incisions and faster recovery
• Works at a leading university medical center in South Korea

Dr. Reyes specializes in gynecology and obstetrics with a focus on reproductive biology – his research includes key publications on fertility and pregnancy outcomes.

• Subspecialized in reproduction biology at Angeles del Pedregal Hospital
• Member of the Mexican Federation of Gynecology and Obstetrics
• Scientific coordinator of the College of Gynecology of Quintana Roo
• Published research on myomectomy and IVF pregnancy rates